 | Up a level |
Albers, Christoph E; Hofstetter, Wilhelm; Sebald, Hans-Jörg; Sebald, Walter; Siebenrock, Klaus A; Klenke, Frank M (2012). L51P - A BMP2 variant with osteoinductive activity via inhibition of Noggin. Bone, 51(3), pp. 401-6. New York, N.Y.: Elsevier 10.1016/j.bone.2012.06.020
Sebald, Hans-Jörg; Klenke, Frank M; Siegrist, Mark; Albers, Christoph E; Sebald, Walter; Hofstetter, Wilhelm (2012). Inhibition of endogenous antagonists with an engineered BMP-2 variant increases BMP-2 efficacy in rat femoral defect healing. Acta biomaterialia, 8(10), pp. 3816-20. Amsterdam: Elsevier 10.1016/j.actbio.2012.06.036
Wernike, E; Hofstetter, W; Liu, Y; Wu, G; Sebald, HJ; Wismeijer, D; Hunziker, EB; Siebenrock, KA; Klenke, FM (2010). Long-term cell-mediated protein release from calcium phosphate ceramics. Journal of biomedical materials research, 92(2), pp. 463-74. Hoboken, N.J.: John Wiley & Sons 10.1002/jbm.a.32411
Gengenbacher, M; Sebald, H-J; Villiger, P M; Hofstetter, W; Seitz, M (2008). Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with Rheumatoid Arthritis and Ankylosing Spondylitis. Annals of the rheumatic diseases, 67(5), pp. 620-4. London: BMJ Publishing Group 10.1136/ard.2007.076711
